Maurice
Posted: January 21, 2022
  • This program is currently closed.

Amount:

$500,000

Type of Program:

Investment


Description:

Accel-Rx Growth Platform is a collaborative partnership-based program focusing on Capital, Connections, and Acumen to help companies prepare for the next stage. Accel-Rx stewards companies through the seed stage of development to a level where they can successfully raise a series A or similar type of venture financing.

Comments on Funding:

Funding from Accel-Rx is up to $500,000 per company, which is further matched by third-party investors.


When It Ends:

Ongoing

Deadline:

Rolling deadline

Eligibility:

The applicant must:

  • Be incorporated in Canada
  • Have validated a technology for therapeutic, diagnostic, or medical device
  • Be the company that has ownership or control of the intellectual property
  • Be valued between $1 - $5 million
  • Have taken previous external funding less than $2 million

Documentation Needed:

Applicants must:

  • Make a presentation to Accel-Rx team for initial screening
  • Submit a pre-proposal if selected
  • Submit a full proposal if selected
  • Make a final presentation to Accel-Rx team and Investment Committee

Other Things to Note:

Program no longer active at the beginning of 2021.

Program Contact:

Accel-RX website

About the author 

Maurice

Maurice (Moe) Muise learned the ins-and-outs of government while an employee of the Government of Canada in Ottawa for 10 years. His current focus is helping small businesses in Ontario to identify and maximize government grants to grow their business.
Click here to learn more about Moe's background and how he can help your business.

Tags

You may also like

Research and Development Grants for Ontario Businesses (2021): 23 Government Incentives to Boost Your R&D

Research and Development Grants for Ontario Businesses (2021): 23 Government Incentives to Boost Your R&D
Success message!
Warning message!
Error message!